Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
3
×
detroit blog main
detroit top stories
gene therapy
gilead sciences
immunotherapy
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
cell therapy
glaxosmithkline
johnson & johnson
multiple myeloma
nonalcoholic steatohepatitis
What
bio
roundup
abbvie’s
ahead
american
annual
approval
ash
biofourmis
biogen’s
biopharmaceutical
blood
borne
bucks
cancer
cancers
celebrate
chance
companies
conference
convo
corner
day
days
diego
drug
earlier
failures
forward
gathering
guide
hematology
holiday
host
labor
largest
latest
littered
looking
medical
Language
unset
Current search:
immunotherapy
×
abbvie
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More